Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diez-Quevedo, C.
Right arrow Articles by Spitzer, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diez-Quevedo, C.
Right arrow Articles by Spitzer, R. L.
Related Collections
Right arrow Culture
Right arrow Other Epidemiology
Psychosomatic Medicine 63:679-686 (2001)
© 2001 American Psychosomatic Society


ORIGINAL ARTICLES

Validation and Utility of the Patient Health Questionnaire in Diagnosing Mental Disorders in 1003 General Hospital Spanish Inpatients

Crisanto Diez-Quevedo, MD, Teresa Rangil, MBM, Luis Sanchez-Planell, MD, Kurt Kroenke, MD and Robert L. Spitzer, MD

From the Department of Psychiatry, Autonomous University of Barcelona; University Hospital "Germans Trias i Pujol" (C.D.-Q. and L.S.-P.) and Biomedical Research Foundation "Germans Trias i Pujol," (T.R.) Badalona, Spain; Regenstrief Institute for Health Care, Department of Medicine (K.K), Indiana University, Indianapolis, Indiana (K.K.); and Department of Psychiatry (R.L.S), Columbia University, New York.

Address reprint requests to: Crisanto Diez-Quevedo, MD, Departament de Psiquiatria, Hospital Universitari Germans Trias i Pujol, Ctra del Canyet, s/n, E-08916 Badalona, Spain. Email: psq{at}ns.hugtip.scs.es


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
OBJECTIVE: To determine whether the Spanish version of the patient health questionnaire (PHQ) has validity and utility for diagnosing mental disorders in general hospital inpatients.

METHODS: Participants in the study were 1003 general hospital inpatients, randomly selected from all admissions over an 18-month period. All of them completed the PHQ, the Beck Depression Inventory (BDI), and measures of functional status, disability days, and health care use, including length of hospital stay. They also had a structured interview with a mental health professional.

RESULTS: A total of 416 (42%) of the 1003 general hospital inpatients had a PHQ diagnosis. There was good agreement between PHQ diagnoses and those of an independent mental health professional (for the diagnosis of any PHQ disorder, {kappa} = 0.74; overall accuracy, 88%; sensitivity, 87%; specificity, 88%), similar to the original English version of the PHQ in primary care patients. Patients with PHQ diagnoses had more functional impairment, disability days, and health care use than did patients without PHQ diagnoses (group main effects for functional status measures and disability days, p < .001; group main effects for health care use, p < .01). The group main effect for hospital length of stay was not significant. An index of depression symptom severity calculated from the PHQ correlated significantly both with the number of depressive symptoms detected at interview and the total BDI score. PHQ administration was well accepted by patients.

CONCLUSIONS: The Spanish version of the PHQ has diagnostic validity in general hospital inpatients comparable to the original English version in primary care.

Key Words: mental disorders/diagnosis • general hospital inpatients • mental status schedule • psychiatric status rating scales • sensitivity and specificity • cost of illness

Abbreviations: PHQ = patient health questionnaire; BDI = Beck Depression Inventory; SF-20 = Medical Outcomes Study Short-Form General Health Survey; PRIME-MD = primary care evaluation of mental disorders; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, 3rd edition revised; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; SD = standard deviation; MHP = mental health professional; ICD-9 = International Classification of Diseases, 9th edition.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
Mental disorders are common and disabling in medical patients, and their influence on health care use and costs has been well established (111). Although less studied than primary care patients, the situation is rather similar in general hospital inpatients (1220), who also show a relationship between mental disorders and variables related to hospitalization, such as length of stay (16, 18, 2123). However, mental disorders are frequently unrecognized and are therefore not treated in this population (13, 22, 24) or in primary care settings (1, 3, 58, 10, 11, 2528).

Several instruments have been designed for the screening of psychopathology in medical patients (2932). However, the PRIME-MD (6) and the PHQ (11) are the first brief instruments to cover a wide range of psychopathology and to diagnose specific disorders by use of diagnostic criteria from the DSM-III-R (33) and DSM-IV (34). PRIME-MD has been translated and validated in Spanish primary care populations (810). This instrument is a 2-stage system in which the patient first completes a self-administered questionnaire that screens for 5 of the most common groups of disorders in primary care: depressive, anxiety, alcohol, somatoform, and eating disorders. For patients who screen positive, the physician then asks specific questions from the clinician evaluation guide. Designed for use in primary care, PRIME-MD has not been used to our knowledge with general hospital inpatients (with the exception of Beck et al. [31], who used only the mood module). Although PRIME-MD has been widely used in clinical research (3542), its use in clinical settings has apparently been limited because of the amount of time required to administer the clinician evaluation guide. For this reason, the authors recently developed and validated a fully self-administered version of the original PRIME-MD, called the PRIME-MD PHQ (11). The 2 components of the original PRIME-MD (the patient questionnaire and the clinician evaluation guide) were combined into a single, 3-page questionnaire that can be entirely self-administered by the patient. The clinician scans the completed questionnaire, verifies positive responses, and applies diagnostic algorithms. The PHQ assesses for threshold disorders (major depressive disorder, panic disorder, other anxiety disorder, and bulimia nervosa) and subthreshold disorders (other depressive disorder, probable alcohol abuse or dependence, and binge eating disorder).

The purpose of the present study was to validate a Spanish version of the PHQ and to demonstrate its utility to enhance the recognition of mental disorders, replicating original data on primary care patients with a sample of medical and surgical inpatients in a tertiary university hospital.1


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
Site and Selection of Subjects
The study was conducted with medical and surgical inpatients between the ages of 18 and 74 years who were admitted to a tertiary university hospital in Spain. The hospital review board approved the study protocol. From April 1997 to September 1998, a total of 35,042 patients were admitted to the hospital. Excluded from this study were 9448 patients who were admitted to intensive care units or for ambulatory major surgery and 10,363 who were either outside the age limits or were admitted to the wards of psychiatry, obstetrics, and substance dependence disorders. Thus, 15,231 patients were potentially eligible for this study, of whom 9590 were randomly selected to participate. Of these, 4088 were not available (eg, because of surgery, other treatments, or tests); 2611 were excluded because of having already been approached in previous admissions (388), illiteracy (399), cognitive impairment (777), physical impairment precluding completion of the questionnaire (978), or non–Spanish-speaking (69); and 1069 either refused to participate or to complete the protocol. Patients who refused to participate in the study were slightly more likely to be men (62% vs. 56%) but were equally represented in medical and surgical wards.

Therefore, 1822 patients were ultimately enrolled and allocated into two groups: 1003 patients who constitute the sample for this report and 819 who were used as a control group for other purposes and are not used at all in this paper. These two groups did not differ in terms of sex, marital status, educational level, specific unit of admittance (medical, surgical, and medical-surgical wards), or length of stay and only slightly differed by age (43.0 vs. 45.3 years). All enrolled subjects provided written informed consent.

Data Collection
Within several days of admission (mean 2.0, SD 4.7), all study patients completed the PHQ. The Spanish version of the PHQ was developed similar to the Spanish version of the original PRIME-MD (9). It should be emphasized that if this Spanish language version is going to be used in a Spanish-speaking population in the United States, some changes may be required because of differences in dialects. Additionally, patients completed other items regarding visits to a physician and disability days during the 3 months prior to hospital admission, their comfort with answering the PHQ questions, and how valuable they believed the PHQ would be to their physicians in understanding and treating the problems they were having (11). Patients also completed SF-20 (4345), which measures functional status in 6 domains, and the BDI (46).

To determine the agreement of PHQ diagnoses with those of a MHP, one of us (T.R.), an experienced clinical psychologist, interviewed all patients face-to-face within 48 hours after they completed the PHQ. The MHP was blind to the results of PHQ. The rationale and additional details of the interview, which used the overview from the Structured Clinical Interview for DSM-III-R (47) and diagnostic questions from the original PRIME-MD, are described elsewhere (6, 9). Statistical analysis was made by use of SYSTAT 9 statistical package (SPSS Inc.).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
Description of Patients
The mean (SD) patient age was 43.0 (14.2) years, with a range from 18 to 74 years; 54.4% were men; all were white; 69.5% were married, 5.3% divorced, and 21.6% never married; 34.3% completed high school. The most common types of physical disorders, following ICD-9 (48) groups, were cardiocirculatory diseases (25.9%), gastrointestinal diseases (22.3%), endocrine-nutritional-metabolic-immune diseases (20.8%), cancer (15.7%), genitourinary diseases (15.7%), locomotor and connective tissue diseases (13.2%), hypertension and related disorders (13.0%), respiratory diseases (12.5%), and infectious diseases (10.3%). The two most frequent main diagnoses at discharge were cancer (11.8%) and ischemic heart disease (4.7%). The total length of stay at the hospital was 12.3 days (SD 11.1).

Accuracy (Agreement With MHPs) and Diagnostic Results of PHQ Evaluations
The operating characteristics of the Spanish version of the PHQ are generally satisfactory (Table 1) and are comparable to those of the original English version (11). Sensitivity was >76% for all individual psychiatric diagnoses (except 69% for "any anxiety disorder") and 87% for any PHQ psychiatric diagnosis. Specificity and overall accuracy were higher than 86% for all measures. Furthermore, the PHQ depression symptom severity score (the sum of scores on the 9 PHQ depressive symptoms, with a possible range of 0–27) correlated strongly with both the number of depressive symptoms recorded during MHP interview (0.71) and the total BDI score (0.76).


View this table:
[in this window]
[in a new window]
 
Table 1. Operating Characteristics of the Spanish Version of the Patient Health Questionnaire in 1003 General Hospital Inpatients—Interview by a Mental Health Professional was the Criterion Standard
 
Regarding diagnoses made by the MHP using the face-to-face structured interview, only 6 (7.2%) cases of major depressive disorder were not recognized as threshold or subthreshold psychiatric diagnoses by the PHQ, 4 (4.6%) cases of other depressive disorders, 10 (5.9%) cases of any mood disorder, none of panic disorder, 20 (11.4%) cases of other anxiety disorders, 7 (6.8%) cases of generalized anxiety disorder, 1 (12.5%) case of bulimia nervosa, none of binge eating disorder, and 24 (14.9%) cases of probable alcohol abuse/dependence. The prevalence of PHQ diagnoses is shown in Table 2.


View this table:
[in this window]
[in a new window]
 
Table 2. Prevalence of Psychiatric Disorders Detected by the Patient Health Questionnaire in 1003 General Hospital Inpatients
 
Relationship of PHQ Results to Functional Status, Health Care Use, Disability Days, and Length of Hospital Stay
Figure 1 shows the mean scores on the 6 scales of the SF-20 for 4 groups of subjects according to PHQ results. Each of the PHQ disorders (except for alcohol abuse/dependence) has at least 1 symptom that must be present for the diagnosis to be made. Patients who did not endorse any of the required symptoms on the PHQ were considered to be symptom-screen–negative. Patients who had at least 1 of the required symptoms but who did not qualify for a diagnosis were considered to be symptom-screen–positive but to have no psychiatric diagnosis. The third and fourth groups met criteria for subthreshold-only and any threshold diagnoses, respectively. Scores were adjusted by analysis of covariance for number of physical disorders, sex, age, and education level. As in the original PRIME-MD and PHQ studies, the symptom-screen–negative group had the highest level of functioning on all of the scales, followed by the symptom-screen–positive group, the subthreshold group, and, finally, the threshold group. The group main effects were all significant (p < .001). Paired comparisons among the four groups by use of Bonferroni adjustment for each of the SF-20 subscales were as follows: the threshold psychiatric diagnosis group was significantly different from the other three groups at p < .005 along all scales. The subthreshold psychiatric diagnosis group was significantly different from the screen-negative group at p < .005 in all scales, but the only difference compared with the screen-positive but no psychiatric diagnosis group was on the health perception scale (p < .05). The screen-positive but no psychiatric diagnosis group was significantly different from the screen-negative group only for the scales of mental health (p < .001) and bodily pain (p < .05).



View larger version (48K):
[in this window]
[in a new window]
 
Fig. 1. Relationship of PHQ results to functional status (SF-20 scales). Because of missing data for some patients, the range of numbers of patients across scales was as follows: symptom-screen–negative, 409 to 422; symptom-screen–positive but no psychiatric diagnosis, 152 to 157; subthreshold psychiatric diagnosis, 197 to 208; and threshold psychiatric diagnosis, 190 to 201.

 
Table 3 presents the mean values of an index of health care use and one of disability in the same 4 groups, along with the length of hospital stay, with scores again adjusted for the variables just noted. As diagnostic status ascended from symptoms but no psychiatric disorder to subthreshold disorder to threshold disorder, there was a progressive increase in the number of visits to a physician and the number of days kept from usual activities in the past 3 months. Regarding the length of hospital stay, there was no significant group effect, even though there was a significant difference between the symptom-screen–negative and the threshold psychiatric diagnosis groups.


View this table:
[in this window]
[in a new window]
 
Table 3. Self-reported Healthcare Use, Disability Days, and Hospital Length of Stay by PHQ Diagnostic Resultsa
 
We also examined how the probability of a threshold PHQ diagnosis varied depending on responses to the question, "How difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?" As shown in Table 4, the percentage of subjects endorsing increasing degrees of difficulty varied significantly (p < .001) among the four different PHQ diagnostic groups. Responses to this single question also correlated with functional impairment as measured by each of the SF-20 scales, ranging from -0.20 (bodily pain) to -0.40 (mental health). The index of depression severity also had high correlations with the SF-20 scales, ranging from -0.34 for role functioning to -0.75 for mental health.


View this table:
[in this window]
[in a new window]
 
Table 4. Answer to Question "How Difficult Have These Problems Made It for You To Do Your Work, Take Care of Things at Home, or Get Along With Other People?" by PHQ Diagnostic Results (No. [%])
 
Recognition of Mental Disorders
We compared the PHQ results to the presence of a diagnosis of any mental disorder at discharge (following the ICD-9 [48] section of mental disorders, and so including several additional diagnoses not included in the PHQ). Of the 206 patients with a threshold psychiatric diagnosis by the PHQ, only 74 (35.9%) had a mental disorder diagnosis at discharge, and of the 210 patients with a subthreshold psychiatric diagnosis, only 59 (28.1%) had a mental disorder diagnosis at discharge. Recognition varied by type of inpatient setting: among patients with a threshold psychiatric diagnosis, 50% of those on medical wards had a mental disorder diagnosis at discharge, compared with 26.6% of those on surgical wards and 9.1% of those on medical-surgical wards. Among patients with a subthreshold psychiatric diagnosis, 46.7% of those on medical wards had a mental disorder diagnosis at discharge, compared with 13.5% of those on surgical wards and 0% of those on medical-surgical wards.

Reaction of Patients to PHQ
The majority of patients (93.3%) said they were "very" or "somewhat" comfortable answering the questions on the PHQ. Likewise, 90.7% believed that the questions were "very" or "somewhat" helpful in getting their physicians to better understand or treat the problems they were having.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
Certainly, the patients included in this study are not fully representative of the general hospital inpatient population. The first step in the decision tree was to exclude from the target population all patients admitted to intensive care, ambulatory major surgery, psychiatry, obstetrics, and substance dependence disorders units, either for the relative unavailability of these patients or because they represented special populations. Patients under age 18 or over age 74 years were also excluded. A second step in the decision tree was to not approach in a second wave patients who were initially unavailable because of surgery, other treatments, or medical tests. Our primary aim was to evaluate psychopathology present on hospital admission, and we wished to decrease the likelihood that major treatments or the results of diagnostic tests would affect types and frequency of mental disorders in a hospitalized population. Patients not available (43%) were somewhat overrepresented in surgical (48%) and medical-surgical (58%) wards. Although this decision tree has a modest impact on the generalizability of our findings to hospital patients not studied, our results regarding the validation and utility of the PHQ in diagnosing mental disorders remain strong.

The self-administered Spanish version of PHQ has diagnostic validity in general hospital inpatients comparable to that of the original English version of PHQ (11) and the original clinician-administered PRIME-MD (6, 9) in primary care. This was demonstrated both by agreement with an independent MHP interview (criterion validity) as well as by the strong association of PHQ diagnoses with indices of functional impairment and health care use (construct validity). PHQ administration was well accepted by patients, and most believed that the questions were helpful in getting their physicians to better understand or treat the problems they were having, even though they were patients admitted to a general hospital for specific medical-surgical problems.

Even though our patients differed from patients in the original PHQ validation study in terms of several demographic (more men and married and fewer divorced) and clinical variables (inpatients vs. primary care patients and more severe medical diagnoses), the operating characteristics of the Spanish version of PHQ are generally satisfactory and comparable to those obtained by the original English version. Agreement between the PHQ and the mental health professional interview ranged between good and strong for all diagnoses. Furthermore, the PHQ index of depression symptom severity correlated strongly with both the number of depressive symptoms recorded during the MHP interview as well as the total Beck Depression Inventory score. Only a minority (12.6%) of the patients with any MHP psychiatric diagnosis was not recognized by the PHQ, and they were overrepresented in the groups of other anxiety disorders and probable alcohol abuse/dependence.

The relationship between PHQ diagnostic status and other patient outcomes in our inpatient sample was similar to that found in previous outpatient studies. As diagnostic status ascended from symptoms but no psychiatric disorder to subthreshold disorder to threshold disorder, there was a progressive increase in functional impairment, health care use, and disability days. The functional status of mentally healthy subjects (the screen-negative group) is lower in our sample, and the number of visits to a physician and the days kept from usual activities during the previous 3 months are higher, which is in accordance with the inpatient status and the more severe physical disorders in our sample. Paired comparisons show fewer differences than Spitzer et al.’s paper (11) between the screen-negative group and the screen-positive but no psychiatric diagnosis group and between the latter and the subthreshold diagnosis group, probably because of the smaller size of our sample and the higher prevalence of probable alcohol abuse/dependence, included in the subthreshold diagnosis group, which has a smaller relationship to functional status (49). Nevertheless, differences were rather similar to those obtained in the original PRIME-MD study (6).

Compared with the original PHQ primary care study, our hospitalized sample had a greater prevalence of any psychiatric diagnosis (42% vs. 28%), both threshold and subthreshold, especially because of a larger proportion of inpatients with mood disorders (26% vs. 16%), other anxiety disorders (12% vs. 7%), and probable alcohol abuse/dependence (13% vs. 7%). Part of these differences may be due to dissimilarities in demographic variables, type of patients (inpatients vs. primary care patients), and greater numbers and severity of physical disorders. Cultural differences may also play a role. For example, in the work of Baca et al. (8) in primary care in Spain, the prevalence of any psychiatric disorder was 54%, mood disorders was 38%, and anxiety disorders was 22%. Our data are generally similar to other studies of mental disorders in medical inpatients (12, 13, 1619).

In contrast to some previous studies (16, 18, 2123), psychiatric diagnoses were only marginally associated with length of stay in our study. This weaker relationship may be due to several factors. First, the PHQ examines a wide spectrum of psychiatric symptom severity ranging from symptoms only to threshold disorders. Some previous inpatient studies focused more on threshold disorders, and it was in this group that our study also found a modest effect on length of stay. Second, the average length of stay in our hospital was relatively long, compared with a number of other hospitals. It may be that psychiatric comorbidity has a greater effect when there are economic and other system pressures to shorten hospital stay.

The number of patients with a PHQ psychiatric diagnosis unrecognized by their physicians was higher in our study than in the original primary care sample (68% vs. 46% for any psychiatric diagnosis). One major reason may be that, in the original study, physicians were explicitly asked whether they believed the patient had a psychiatric diagnosis. Physicians in our study were unprompted and, instead, we compared the PHQ results to the presence of a diagnosis of any ICD-9 mental disorder at discharge (48). It is also possible that the detection of psychiatric diagnoses is lower in inpatient settings, where the overriding concern is the acute medical or surgical illnesses triggering hospital admission and acute care. However, substantial differences existed even within our inpatient sample, with the recognition on surgical wards being considerably lower than on the medical wards. In fact, the recognition rates on the medical wards were comparable to that demonstrated in primary care outpatient studies.

Because of its easy and well-accepted administration and its power to detect psychiatric diagnoses, the PHQ could be a useful screening procedure not only in primary care but also in general hospital care. Enhanced recognition of mental disorders, if coupled with appropriate treatment, would have the potential to improve the functional status of such patients and reduce their health care use. The busy hospital setting, however, may not always be the ideal setting to adequately address mental disorders, particularly with competing acute medical and surgical illnesses and economic pressures to shorten hospital stays (50). Also, a proportion of psychiatric symptoms present on admission may decrease by hospital discharge (17, 51). For these reasons, hospitalized patients in whom a psychiatric diagnosis is detected may warrant closer outpatient follow-up, where treatment could be instituted. As suggested in the original PHQ study and confirmed by many others, additional support may also be necessary for the primary care physicians to adequately manage those disorders that are detected (11, 52).


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
This study received financial support by a full grant from the Spanish Ministry of Health–Health Research Fund (Fondo de Investigaciones Sanitarias, project 97/1184). T. Rangil was a FIS Research Fellow (97/1184). The development of the original PHQ was underwritten by an educational grant from Pfizer US Pharmaceuticals Inc, New York, NY. PRIME-MD is a trademark of Pfizer Inc. Copyright held by Pfizer Inc.

The authors wish to thank Maria Vilchez, DI, and Rosa Fernandez-Valdes, MBM, for their support in data collection and Montserrat Prats, MD, for her clinical support, as well as the health and administration staff of the University Hospital "Germans Trias i Pujol" for their help in conducting the study.


    NOTES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 
1 Copies of the Spanish version of PHQ are available upon request. Back

Received for publication April 14, 2000.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Kessler LG, Cleary PD, Burke JD Jr. Psychiatric disorders in primary care. Results of a follow-up study. Arch Gen Psychiatry 1985; 42: 583–7.[Abstract]
  2. Barrett JE, Barrett JA, Oxman TE, Gerber PD. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988; 45: 1100–6.[Abstract]
  3. Schulberg HC, Burns BJ. Mental disorders in primary care: epidemiologic, diagnostic, and treatment research directions. Gen Hosp Psychiatry 1988; 10: 79–87.[Medline]
  4. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267: 1478–83.[Abstract]
  5. Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994; 272: 1741–8.[Abstract]
  6. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, Brody D, Johnson JG. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272: 1749–56.[Abstract]
  7. Vazquez-Barquero JL, Garcia J, Simon JA, Iglesias C, Montejo J, Herran A, Dunn G. Mental health in primary care. An epidemiological study of morbidity and use of health resources. Br J Psychiatry 1997; 170: 529–35.[Abstract/Free Full Text]
  8. Baca Baldomero E, Saiz Ruiz J, Aguera Ortiz LF, Caballero Martinez L, Fernandez-Liria A, Ramos Brieva JA, Gil Miguel A, Madrigal Jimenez M, Porras Chavarino A. Prevalencia de los trastornos psiquiatricos en atencion primaria usando el cuestionario PRIME-MD. Aten Primaria 1999; 23: 275–9.[Medline]
  9. Baca E, Saiz J, Aguera L, Caballero L, Fernandez-Liria A, Ramos J, Gil A, Madrigal M, Porras A. Validacion de la version española del PRIME-MD: un procedimiento para el diagnostico de trastornos mentales en atencion primaria. Actas Esp Psiquiatr 1999; 27: 375–83.[Medline]
  10. Martinez Bernardos R, Baylin Larios A, Ortiz Jimenez MF. Podemos detectar trastornos mentales en atencion primaria? Utilidad y concordancia de dos instrumentos diagnosticos. Aten Primaria 1999; 23: 285–8.[Medline]
  11. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999; 282: 1737–44.[Abstract/Free Full Text]
  12. Levenson JL, Hamer R, Silverman JJ, Rossiter LF. Psychopathology in medical inpatients and its relationship to length of hospital stay: a pilot study. Int J Psychiatry Med 1986–1987; 16: 231–6.[Medline]
  13. Hengeveld MW, Ancion FA, Rooijmans HG. Prevalence and recognition of depressive disorders in general medical inpatients. Int J Psychiatry Med 1987; 17: 341–9.[Medline]
  14. Yang LL, Zuo CY, Su LY, Eaton MT. Depression in Chinese medical inpatients. Am J Psychiatry 1987; 144: 226–8.[Abstract/Free Full Text]
  15. Lykouras E, Loannidis C, Voulgari A, Jemos J, Tzonou A. Depression among general hospital patients in Greece. Acta Psychiatr Scand 1989; 79: 148–52.[Medline]
  16. Levenson JL, Hamer RM, Rossiter LF. Relation of psychopathology in general medical inpatients to use and cost of services. Am J Psychiatry 1990; 147: 1498–503.[Abstract/Free Full Text]
  17. Kathol RG, Wenzel RP. Natural history of symptoms of depression and anxiety during inpatient treatment on general medicine wards. J Gen Intern Med 1992; 7: 287–93.[Medline]
  18. Levenson JL, Hamer RM, Rossiter LF. Psychopathology and pain in medical in-patients predict resource use during hospitalization but not rehospitalization. J Psychosom Res 1992; 36: 585–92.[Medline]
  19. Cathebras P, Mosnier C, Levy M, Bouchou K, Rousset H. Depistage de la depression chez les patients hospitalises en medecine. Comparison de deux echelles d’autoevaluation et du jugement des cliniciens a un questionnaire structure. Encephale 1994; 20: 311–7.[Medline]
  20. Strain JJ, Hammer JS, Fulop G. APM task force on psychosocial interventions in the general hospital inpatient setting. A review of cost-offset studies. Psychosomatics 1994; 35: 253–62.[Abstract/Free Full Text]
  21. Fulop G, Strain JJ, Vita J, Lyons JS, Hammer JS. Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. Am J Psychiatry 1987; 144: 878–82.[Abstract/Free Full Text]
  22. Fulop G. Anxiety disorders in the general hospital setting. Psychiatr Med 1990; 8: 187–95.[Medline]
  23. Verbosky LA, Franco KN, Zrull JP. The relationship between depression and length of stay in the general hospital patient. J Clin Psychiatry 1993; 54: 177–81.[Medline]
  24. Silverstone PH. Prevalence of psychiatric disorders in medical inpatients. J Nerv Ment Dis 1996; 184: 43–51.[Medline]
  25. Borus JF, Howes MJ, Devins NP, Rosenberg R, Livingston WW. Primary health care providers’ recognition and diagnosis of mental disorders in their patients. Gen Hosp Psychiatry 1988; 10: 317–21.[Medline]
  26. Ormel J, Koeter MW, van den Brink W, van de Willige G. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 1991; 48: 700–6.[Abstract]
  27. Rydon P, Redman S, Sanson-Fisher RW, Reid AL. Detection of alcohol-related problems in general practice. J Stud Alcohol 1992; 53: 197–202.[Medline]
  28. Üstün TB, Sartorius N. Mental illness in general health care: an international study. New York: John Wiley & Sons; 1995.
  29. Goldberg D, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. BMJ 1988; 297: 897–9.
  30. Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995; 122: 913–21.[Abstract/Free Full Text]
  31. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997; 35: 785–91.[Medline]
  32. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439–45.[Medline]
  33. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd Edition. Washington, D. C.: APA; 1987.
  34. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th Edition. Washington, D. C.: APA; 1994.
  35. Philbrick JT, Connelly JE, Wofford AB. The prevalence of mental disorders in rural office practice. J Gen Intern Med 1996; 11: 9–15.[Medline]
  36. Kobak KA, Taylor LH, Dottl SL, Greist JH, Jefferson JW, Burroughs D, Mantle JM, Katzelnick DJ, Norton R, Henk HJ, Serlin RC. A computer-administered telephone interview to identify mental disorders. JAMA 1997; 278: 905–10.[Abstract]
  37. Kroenke K, Jackson JL, Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med 1997; 103: 339–47.[Medline]
  38. Parker T, May PA, Maviglia MA, Petrakis S, Sunde S, Gloyd SV. PRIME-MD: its utility in detecting mental disorders in American Indians. Int J Psychiatry Med 1997; 27: 107–28.[Medline]
  39. Valenstein M, Dalack G, Blow F, Figueroa S, Standiford C, Douglass A. Screening for psychiatric illness with a combined screening and diagnostic instrument. J Gen Intern Med 1997; 12: 679–85.[Medline]
  40. Leopold KA, Ahles TA, Walch S, Amdur RJ, Mott LA, Wiegand-Packard L, Oxman TE. Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys 1998; 42: 1105–12.[Medline]
  41. O’Malley PG, Jackson JL, Kroenke K, Yoon K, Hornstein E, Dennis GJ. The value of screening for psychiatric disorders in rheumatology referrals. Arch Intern Med 1998; 158: 2357–62.[Abstract/Free Full Text]
  42. O’Malley PG, Wong PW, Kroenke K, Roy MJ, Wong RK. The value of screening for psychiatric disorders prior to upper endoscopy. J Psychosom Res 1998; 44: 279–87.[Medline]
  43. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–35.[Medline]
  44. Alonso J, Prieto L, Anto JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barcelona) 1995; 104: 771–6.[Medline]
  45. Ayuso-Mateos JL, Lasa L, Vazquez-Barquero JL, Oviedo A, Diez-Manrique JF. Measuring health status in psychiatric community surveys: internal and external validity of the Spanish version of the SF-36. Acta Psychiatr Scand 1999; 99: 26–32.[Medline]
  46. Schwab J, Bialow M, Clemmons R, Martin P, Holzer C. The Beck depression inventory with medical inpatients. Acta Psychiatr Scand 1967; 43: 255–66.[Medline]
  47. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624–9.[Abstract]
  48. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 9th revision. Genève: WHO; 1977.
  49. Johnson JG, Spitzer RL, Williams JB, Kroenke K, Linzer M, Brody D, deGruy F, Hahn S. Psychiatric comorbidity, health status, and functional impairment associated with alcohol abuse and dependence in primary care patients: findings of the PRIME MD-1000 study. J Consult Clin Psychol 1995; 63: 133–40.[Medline]
  50. Kroenke K. Discovering depression in medical patients: reasonable expectations. Ann Intern Med 1997; 126: 463–5.[Free Full Text]
  51. Kroenke K, Stump T, Clark DO, Callahan CM, McDonald CJ. Symptoms in hospitalized patients: outcome and satisfaction with care. Am J Med 1999; 107: 425–31.[Medline]
  52. Kroenke K, Taylor-Vaisey A, Dietrich AJ, Oxman TE. Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 2000; 41: 39–52.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann Fam MedHome page
A. Karasz and L. Watkins
Conceptual Models of Treatment in Depressed Hispanic Patients
Ann. Fam. Med, November 1, 2006; 4(6): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
A. Cherrington, G. X. Ayala, B. Sleath, and G. Corbie-Smith
Examining knowledge, attitudes, and beliefs about depression among latino adults with type 2 diabetes.
The Diabetes Educator, July 1, 2006; 32(4): 603 - 613.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
B. Lowe, I. Schenkel, C. Carney-Doebbeling, and C. Gobel
Responsiveness of the PHQ-9 to Psychopharmacological Depression Treatment
Psychosomatics, February 1, 2006; 47(1): 62 - 67.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. M. Feldman, M. I. Siddique, E. Morales, B. Kaminski, S.-E. Lu, and P. M. Lehrer
Psychiatric Disorders and Asthma Outcomes Among High-Risk Inner-City Patients
Psychosom Med, November 1, 2005; 67(6): 989 - 996.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
B. Lowe, L. Willand, W. Eich, S. Zipfel, A. D. Ho, W. Herzog, and C. Fiehn
Psychiatric Comorbidity and Work Disability in Patients With Inflammatory Rheumatic Diseases
Psychosom Med, May 1, 2004; 66(3): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
Other Articles Noted
Evid. Based Ment. Health, February 1, 2002; 5(1): 8 - 8.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diez-Quevedo, C.
Right arrow Articles by Spitzer, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diez-Quevedo, C.
Right arrow Articles by Spitzer, R. L.
Related Collections
Right arrow Culture
Right arrow Other Epidemiology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS